gastrointestinal cancer


Treatment for gastrointestinal (GI) tumors often requires a combination of radiation therapy, chemotherapy and surgery, which can be difficult for patients to tolerate due to the proximity of many important abdominal organs. In some cases, conventional radiotherapy is not even an option because of the high risk of damaging surrounding healthy tissues.

The progresses regarding the diagnosis and the treatment of gastrointestinal and pancreatic neuroendocrine tumors (NETs) widely opened the doors for more trials and protocols based on Radiotheranostics treatments for GI tumors.

Sources: Research Gate, IBA



177Lu-IPN-01087 (pancreas cancer)

177Lu-MVT-1075 (pancreas cancer)

188Re-P2045 (Tozaride) (pancreatic cancer-lung cancer)

224Ra-RadSpherin (colorectal cancer) 

225Ac-Lintuzumab (225Ac-Actimab-A™) (colon cancer)


Compassionate Use Program (CUP)

CUP enables patients with life-threatening diseases, such as advanced cancer, to resort to experimental treatments when standard anti-cancer solutions and access to clinical trials are not an option. Access to CUP programs depends on local regulations and can vary from one treatment to another.

Ask your referring physicians for more information regarding CUP.